Institute and Department of Physiology and Immunology, Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.
Scientific Centre of Excellence for Personalized Health Care, University of Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.
Am J Physiol Heart Circ Physiol. 2021 Apr 1;320(4):H1609-H1624. doi: 10.1152/ajpheart.00620.2020. Epub 2021 Mar 5.
This study aimed to determine the mechanosensing role of angiotensin II type 1 receptor (ATR) in flow-induced dilation (FID) and oxidative stress production in middle cerebral arteries (MCA) of Sprague-Dawley rats. Eleven-week old, healthy male Sprague-Dawley rats on a standard diet were given the ATR blocker losartan (1 mg/mL) in drinking water (losartan group) or tap water (control group) ad libitum for 7 days. Blockade of ATR attenuated FID and acetylcholine-induced dilation was compared with control group. Nitric oxide (NO) synthase inhibitor -nitro-l-arginine methyl ester (l-NAME) and cyclooxygenase inhibitor indomethacin (Indo) significantly reduced FID in control group. The attenuated FID in losartan group was further reduced by Indo only at Δ100 mmHg, whereas l-NAME had no effect. In losartan group, Tempol (a superoxide scavenger) restored dilatation, whereas Tempol + l-NAME together significantly reduced FID compared with restored dilatation with Tempol alone. Direct fluorescence measurements of NO and reactive oxygen species (ROS) production in MCA, in no-flow conditions revealed significantly reduced vascular NO levels with ATR blockade compared with control group, whereas in flow condition increased the NO and ROS production in losartan group and had no effect in the control group. In losartan group, Tempol decreased ROS production in both no-flow and flow conditions. ATR blockade elicited increased serum concentrations of ANG II, 8-iso-PGF2α, and TBARS, and decreased antioxidant enzyme activity (SOD and CAT). These results suggest that in small isolated cerebral arteries: ) AT receptor maintains dilations in physiological conditions; ) ATR blockade leads to increased vascular and systemic oxidative stress, which underlies impaired FID. The ATR blockade impaired the endothelium-dependent, both flow- and acetylcholine-induced dilations of MCA by decreasing vascular NO production and increasing the level of vascular and systemic oxidative stress, whereas it mildly influenced the vascular wall inflammatory phenotype, but had no effect on the systemic inflammatory response. Our data provide functional and molecular evidence for an important role of AT receptor activation in physiological conditions, suggesting that AT receptors have multiple biological functions.
本研究旨在确定血管紧张素 II 型 1 型受体 (ATR) 在流量诱导扩张 (FID) 和大脑中动脉 (MCA) 氧化应激产生中的机械感知作用。11 周龄、健康雄性 Sprague-Dawley 大鼠在标准饮食下,自由饮用 ATR 阻滞剂氯沙坦(1mg/mL)的饮用水(氯沙坦组)或自来水(对照组)7 天。与对照组相比,ATR 阻断减弱了 FID 和乙酰胆碱诱导的扩张。一氧化氮 (NO) 合酶抑制剂 -硝基-l-精氨酸甲酯 (l-NAME) 和环氧化酶抑制剂吲哚美辛 (Indo) 显著降低了对照组的 FID。氯沙坦组的 FID 进一步减弱,仅在Δ100mmHg 时 Indo 降低,而 l-NAME 无影响。在氯沙坦组中,Tempol(超氧化物清除剂)恢复了扩张,而 Tempol + l-NAME 一起与单独使用 Tempol 相比,显著降低了 FID。在无流条件下,MCA 中 NO 和活性氧 (ROS) 产生的直接荧光测量显示,与对照组相比,ATR 阻断后血管中 NO 水平显著降低,而在流量条件下,氯沙坦组中 NO 和 ROS 产生增加,而对照组没有影响。在氯沙坦组中,Tempol 降低了无流和流动条件下的 ROS 产生。ATR 阻断导致血清中 ANG II、8-异-PGF2α 和 TBARS 浓度升高,抗氧化酶活性 (SOD 和 CAT) 降低。这些结果表明,在小型分离的脑动脉中:1)AT 受体在生理条件下维持扩张;2)ATR 阻断导致血管和全身氧化应激增加,这是 FID 受损的基础。ATR 阻断通过降低血管中 NO 的产生和增加血管和全身氧化应激水平,减弱了内皮依赖性、流量和乙酰胆碱诱导的 MCA 扩张,而对血管壁炎症表型影响轻微,但对全身炎症反应没有影响。我们的数据为 AT 受体激活在生理条件下的重要作用提供了功能和分子证据,表明 AT 受体具有多种生物学功能。